180 Life Sciences grants stock options to officers and directors; committee chairs changed

FORUM MARKETS Inc

On June 17, 2025, board approved option grants: CEO Blair Jordan (410,000 shares), CAO Eric Van Lent (25,000), Lead Director Ryan Smith (255,000), directors Shoemaker (165,000) and Steinman (110,000).
Board appointed Stephen Shoemaker as Audit Committee Chair; Ryan Smith as Compensation Committee Chair, effective June 17, 2025.
Grants exempt from registration under Section 4(a)(2) of Securities Act; recipients are accredited investors.

item 3.02item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.